Particulate delivery systems for vaccination against bioterrorism agents and emerging infectious pathogens

Area of Science:

• Nanomedicine and Nanobiotechnology
• Vaccinology
• Biodefense

Background:

• Bioterrorism agents and emerging infectious pathogens pose significant national security and public health threats.
• Traditional vaccine approaches (attenuated, inactivated, subunit) face challenges with safety, immunogenicity, and efficacy.
• Recent outbreaks like Ebola and Zika highlight the need for robust countermeasures.

Purpose of the Study:

• To review the current research on particulate vaccine delivery systems for biodefense.
• To highlight the advantages of nanoparticles and microparticles as vaccine platforms.
• To discuss their potential against bioterrorism agents and emerging infectious diseases.

Main Methods:

• Review of current scientific literature on particulate vaccine delivery systems.
• Analysis of research efforts in developing these systems for biodefense applications.
• Evaluation of the benefits of nanoparticle and microparticle platforms.

Main Results:

• Particulate vaccine systems offer stable antigen delivery and co-delivery of adjuvants.
• Biocompatible materials lead to low reactogenicity and enhanced immune responses (humoral and cellular).
• Nanoparticles and microparticles show promise for both systemic and mucosal immunity.

Conclusions:

• Particulate vaccine delivery systems are a promising platform for developing novel biodefense vaccines.
• These systems overcome limitations of traditional vaccines, offering improved safety and efficacy.
• Further research and clinical development are warranted for these advanced vaccine platforms.